Idarubicin
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2640 publications
Direct interaction between cancer cells and fibroblasts promotes early chemoresistance to standard-of-care drug therapy in small cell lung cancer (SCLC).
Journal: bioRxiv : the preprint server for biology
Published: May 07, 2026
Optical Spectral Fingerprinting Enables Sensitive Detection of Anthracycline Chemotherapeutics in Synthetic Clinical Biofluids.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
The Relationship between OPN, NLR and Chemotherapy Efficacy in Patients with Acute Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: March 18, 2026
Myopericarditis After Combined Idarubicin and Quizartinib in FLT3-ITD-Positive AML.
Journal: JACC. Case reports
Published: March 11, 2026
Clinical and Radiological Outcomes Comparison of Degradable Starch Microspheres TACE with Idarubicin vs. Epirubicin Protocol in Patients with HCC.
Journal: Diagnostics (Basel, Switzerland)
Published: March 11, 2026
Ziftomenib (Komzifti) for acute myeloid leukemia.
Journal: The Medical letter on drugs and therapeutics
Published: March 07, 2026
Real-World Treatment Patterns and Outcomes of Patients With Acute Myeloid Leukemia in Japan in the Pre-venetoclax Era.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 16, 2026
A Rare Case of Acute Promyelocytic Leukemia with ider(17)(q10)t(15;17)(q22;q21) and FLT3-ITD Mutation.
Journal: Clinical laboratory
Published: February 11, 2026
Integrating high-fidelity hiPSC-cardiomyocytes with AI-driven modeling for enhanced proarrhythmic risk assessment.
Journal: Archives of toxicology
Published: February 09, 2026
Improved outcomes of the refined risk-stratification and risk-adapted therapy in children with acute myeloid leukemia: final results of the AIEOP AML 2013.
Journal: Journal of hematology & oncology
Published: February 08, 2026
Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.
Journal: American journal of hematology
Published: February 05, 2026
Integrated computational and experimental approaches for drug repurposing targeting key Mycobacterium tuberculosis proteins.
Journal: Molecular diversity
Published: January 30, 2026
Last Updated: 06/30/2026